ONO PHARMACEUTICAL CO., LTD.

President and Representative Director: Gyo Sagara

Code No: 4528 at the 1st section of the Tokyo Stock Exchange Inquiries: Yukio Tani, Managing Director, Corporate Communications

October 31, 2017

Notice Regarding Completion of Cancellation of Treasury Shares

Osaka, Japan, October 31, 2017 - Ono Pharmaceutical Co., Ltd. (President, Representative Director and CEO, Gyo Sagara; "the Company") announced that, as resolved at the meeting of the Board of Directors held on June 13, 2017, it completed cancellation of treasury shares pursuant to the provisions of Article 178 of the Companies Act.

Particulars

  1. Class of shares cancelled: Common stock of the Company

  2. Total number of shares cancelled: 45,896,100 shares

    (7.79% of total issued shares prior to cancellation)

  3. Date of cancellation: October 31, 2017

(Reference)

The total number of issued shares (after cancellation) 543,341,400 shares

ONO Pharmaceutical Co. Ltd. published this content on 31 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 October 2017 04:02:03 UTC.

Original documenthttp://www.ono.co.jp/eng/news/pdf/sm_cn171031_1.pdf

Public permalinkhttp://www.publicnow.com/view/B3F66F7231723684DF6BFFCD915FA13DDCF5219A